HEAL iPad platform aims to improve patient handoff, reduce nurse overtime

While some doctors and nurses are putting down their iPads, others are picking them up.Hubbard Hill Retirement Community in Elkhart, Indiana is paying less nurse overtime and improving communication among nurses and doctors thanks to iPads and a new program developed by a nearby startup called Carex Technologies.Carex’s first product, HEAL (Handoffs for Extended/Assisted Living), [...]

[Read more of this report]


PU tech transfer chief: ‘Keep breathing innovative thinking into your OTC’

Purdue University spun off 11 new companies in 2010, making it the sixth most successful university technology commercialization program in the country for creating startups, according to the Association of University Technology Managers.It tied that number in 2011 and inked a total of 99 commercialization deals.With a gross royalty income of $3.9 million, the university [...]

[Read more of this report]


Why one medical device manufacturer isn’t worried about losing work to Asia

There’s lots of talk about companies moving medical device manufacturing work overseas in the wake of the device tax next year. But executives at a Fort Wayne, Indiana-based medical device contract manufacturer say they’ve lately seen a trend in the opposite direction.L.H. Medical manufactures surgical instruments and implants, and focuses its efforts on difficult parts [...]

[Read more of this report]


Pharma startup led by Lilly Ventures execs raises $4.6 million

A recently formed, Indianapolis-based pharmaceutical company is in the middle of a $15 million equity offering, according to a Securities and Exchange Commission filing made last week.Esanex Inc.’s principal place of business is listed as the office of Lilly Ventures, the venture capital firm that spun out of Eli Lilly and Co. in 2009 with [...]

[Read more of this report]


BioCrossroads announces New Venture Competition for life sciences companies

This post is sponsored by BioCrossroads.At a press conference today announcing the Indiana Seed Fund II (ISFII), BioCrossroads also launched the inaugural BioCrossroads New Venture Competition presented by Krieg DeVault, an early stage business competition open to life sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology companies holding a substantial nexus to [...]

[Read more of this report]


BioCrossroads forms Indiana Seed Fund II for early-stage life science companies

This post is sponsored by BioCrossroads.BioCrossroads announced today the formation of the Indiana Seed Fund II (the Fund), an early-stage capital fund focused on identifying, creating and developing the next generation of Indiana-based life sciences companies. The $8.25 million fund is a follow-on to the Indiana Seed Fund I, a $6 million fund that is [...]

[Read more of this report]


EQUIPT handles the paperwork so global innovators can focus on devices

Quality management. Documentation. Process controls and validation. Doesn’t that all sound like fun?These complex parts of the medical device development and commercialization process are where Keith Pennington and Vishaka Rajaram are most comfortable and most passionate — so much so that they formed their own business to help other companies with them.Pennington and Rajaram run [...]

[Read more of this report]


Postoperative pain pump maker looking to raise millions

A medical device maker hoping to drive down the use of narcotics and improve postoperative recovery with disposable pain pumps is hoping to raise $6.75 million, according to two recent U.S. Securities and Exchange Commission filings.Indianapolis-based Symbios Medical Products develops, manufactures and markets portable, disposable pain pumps that attach to catheters to deliver non-narcotic pain [...]

[Read more of this report]


Merck’s $1 billion deal includes phase 3 ovarian cancer therapeutic

Merck (NYSE:MRK) has forged a deal with a biopharmaceutical company for its phase 3 platinum-resistant ovarian cancer treatment and nonsmall cell lung cancer in mid-stage development in a deal valued at up to $1 billion.Under the terms of the deal, Merck, through a subsidiary, will get worldwide rights to develop and commercialize vintafolide for ovarian [...]

[Read more of this report]


Beyond buzzword: Platform technology will rule the future of med tech

1. Start with science.2. Find a partner or adviser who has a grip on the evolving regulatory environment.3. Shift your thinking to the context of enabling a comprehensive solution for managing an illness.That’s an idea of what the business model of a successful medtech company looks like in 2012, according to two healthcare consultants.Dane Stout [...]

[Read more of this report]


Older Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics